Health Cor Management, L.P. Galapagos Nv Transaction History

Health Cor Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$52.3 - $71.59 $1.65 Million - $2.26 Million	31,540 Added 132.86%	55,280 $3.09 Million
Q1 2022 May 16, 2022	BUY	$51.32 - $68.5 $1.22 Million - $1.63 Million	23,740 New	23,740 $1.47 Million
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $2.14 Million - $2.88 Million	-41,080 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $469,625 - $568,378	6,820 Added 19.91%	41,080 $2.83 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $2.61 Million - $3.84 Million	34,260 New	34,260 $2.64 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.